A pioneer in microarray technology and a leader in genomics analysis, Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world.
Cancer Genetics Italia S.r.l. (Italia) was founded in 2009 and is a wholly owned subsidiary of Cancer Genetics Inc. (CGI), which is located in Rutherford, New Jersey (U.S.A.). CGI’s affiliation with major cancer centers, such as the Memorial Sloan-Kettering Cancer Center, the National Cancer Institute, and the Mayo Clinic, along with the firm’s foundation in world-class scientific Knowledge has enabled CGI to develop strong intellectual properties (IP) in solid and blood-borne cancers. It is from this foundation that CGI Italia draws its ability to design and manufacture proprietary DNA-FISH Probes. Our DNA-FISH Probes detect a range of genetic aberrations such as translocations and copy number changes and are IP protected.
EntroGen is a Los Angeles-based biotechnology company with a primary focus on molecular diagnostics in the areas of hematology and oncology. EntroGen has a growing commercial portfolio of real-time PCR-based tests, with many of its products being used to guide and monitor targeted therapies for various malignancies. Through a network of distributors, EntroGen’s footprint reaches every corner of the globe to deliver reliable and innovative tools to researchers and clinicians.
Genekam Biotechnology AG was found in 1999. It started offering DNA-Tests in 2001. From 2004, it started development of PCR kits exporting to 5 countries, today (2014) it exports to 70 countries in the world. Genekam covers different targets like Influenza viruses, Flaviviruses, Herpes viruses, Mycobacterium, Tick borne pathogens, Chlamydia, Mycoplasma, Cancer, food pathogens like Salmonella, food adulteration etc. From 2005, it starts doing research in field of stem cell as well as flow cytometry applications. Not only this, it has developed very simple way of isolation of mononuclear cell cells from blood, which generates much great number of cells against density gradient method. Now it is doing research to develop clinical nanotechnological solutions for better health.
Horizon Diagnostics (HDx), a business unit of Horizon Discovery Ltd, is a leading provider of genetically defined, human genomic reference standards, including FFPE cell line sections and purified gDNA. These standards offer a sustainable source of reference material to laboratories, proficiency schemes and manufacturers, providing an unprecedented level of control.
Immundiagnostik AG, Bensheim, Germany, specialises in developing and producing innovative parameters and detection methods for use in laboratories and in medical research. Our main focus is the development of immunological methods for servicing unmet specialised demands of laboratory diagnosis. We concentrate on the development and production of laboratory diagnostics -for the identification of disease potential, -for differential diagnosis and -for therapeutic drug monitoring. Our portfolio consists of Immunoassays (ELISA, RIA), HPLC tests, gene-based diagnostic tests (PCR), photometric tests. ur product range is completed by mono- and polyclonal antibodies, research reagents, and custom analysis.
ZJ Bio-tech is an innovative and continuously developing molecular diagnostic company, who completely focuses on developing, manufacturing and sales of high-qualified real time PCR diagnostic reagents and DNA/RNA extraction reagent/instrument. ZJ’s products are ISO 9001&ISO 13485 certified and CE marked. Total deeply understanding of needs from customers both in clinic and research and providing the innovative products and service with cutting-edge molecular diagnostic technologies impel ZJ to grow fast and continuously in the life science technology field.
Oxford Gene Technology (OGT) provides world-class genetics research solutions to leading clinical and academic research institutions. The Group''s CytoSure™, Cytocell® and Genefficiency™ range of microarray, FISH and next generation sequencing products and services deliver high-quality, high-throughput genetic analysis, enabling accurate identification of the causative variation underlying genetic disease.
Copyright © Biocom Diagnostics